Experts to call for drug reclassification in promotion of OTC drugs.

Published: 2007-08-22 07:00:00

Updated: 2007-08-22 07:00:00

Experts said that the non-prescription drug markets could be activated by reclassifying the prescription and non-prescription drugs instead of the current fixed rate system, which is implemented from this month.

Mr. Chung Myeong-jin, the chief of the industry analysis and statistic team of the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK